T. Rowe Price Associates
STTK icon

T. Rowe Price Associates’s Shattuck Labs STTK Stock Holding History

T. Rowe Price Associates’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3M Buy
2,641,076
+858,288
+48% +$5.35M ﹤0.01% 1172
2026
Q1 		$11.5M Sell
1,782,788
-143,352
-7% -$680K ﹤0.01% 1184
2025
Q4 		$7.03M Buy
+1,926,140
New +$4.6M ﹤0.01% 1306
2025
Q2 		– Sell
-12,603
Closed -$12K – 3145
2025
Q1 		$12K Hold
12,603
– – ﹤0.01% 3024
2024
Q4 		$16K Sell
12,603
-19,300
-60% -$23.9K ﹤0.01% 3001
2024
Q3 		$112K Hold
31,903
– – ﹤0.01% 2797
2024
Q2 		$124K Buy
31,903
+12,603
+65% +$102K ﹤0.01% 2715
2024
Q1 		$173K Hold
19,300
– – ﹤0.01% 2663
2023
Q4 		$138K Hold
19,300
– – ﹤0.01% 2651
2023
Q3 		$30K Hold
19,300
– – ﹤0.01% 2831
2023
Q2 		$61K Hold
19,300
– – ﹤0.01% 2779
2023
Q1 		$57K Hold
19,300
– – ﹤0.01% 2772
2022
Q4 		$44K Hold
19,300
– – ﹤0.01% 2827
2022
Q3 		$53K Hold
19,300
– – ﹤0.01% 2830
2022
Q2 		$78K Sell
19,300
-2,316
-11% -$8.39K ﹤0.01% 2807
2022
Q1 		$92K Buy
21,616
+500
+2% +$2.84K ﹤0.01% 2864
2021
Q4 		$180K Buy
+21,116
New +$291K ﹤0.01% 2782

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates's STTK Position: Q2 2026 in Review

T. Rowe Price Associates increased its Shattuck Labs (STTK) stake by 48% in Q2 2026, buying an estimated $5.35M and bringing the position to 2,641,076 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

T. Rowe Price Associates first reported a position in STTK in Q4 2021 and has held it in 17 quarters since. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • T. Rowe Price Associates held 2,641,076 shares of Shattuck Labs worth $18.3M as of Q2 2026.
  • T. Rowe Price Associates bought 858,288 Shattuck Labs shares in Q2 2026, an estimated $5.35M.
  • Shattuck Labs made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1172 holding.
  • T. Rowe Price Associates first reported a position in Shattuck Labs in Q4 2021 and has held it in 17 quarters since.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.